Lemaitre Vascular (LMAT) Share-based Compensation (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Share-based Compensation of $2.1 million for Q1 2026, up 3506.9% year-over-year from $58000.0 in Q1 2025, and little changed quarter-over-quarter from $2.1 million in Q4 2025.
Lemaitre Vascular (LMAT) Share-based Compensation (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Share-based Compensation for 17 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 3506.9% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $7.9 million (up 56.94% YoY), while the FY2025 annual figure was $20.4 million, up 11.48% from the prior year.
- Share-based Compensation was little changed at $2.1 million in Q1 2026 per LMAT's latest filing, from $2.1 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.1 million in Q4 2025 and bottomed at $58000.0 in Q1 2025.
- Historically, Share-based Compensation has averaged $1.4 million across 5 years, with a median of $1.4 million in 2023.
- Annual changes were most pronounced in 2025 — Share-based Compensation plunged 96.4% — and 2026, when it soared 3506.9%.
- Lemaitre Vascular's Share-based Compensation stood at $684000.0 in 2022, then jumped by 105.26% to $1.4 million in 2023, then gained by 23.86% to $1.7 million in 2024, then gained by 20.53% to $2.1 million in 2025, then retreated by 0.19% to $2.1 million in 2026.
- Business Quant data shows LMAT's Share-based Compensation at $2.1 million in Q1 2026, $2.1 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 2.09 Mn |
| Mar 31, 2026 | 2.09 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 58,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 1.74 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.61 Mn |